Patterns and socio-demographic correlates of domain-specific physical activities and their associations with adiposity in the China Kadoorie Biobank study.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 4138397)

Published in BMC Public Health on August 09, 2014

Authors

Huaidong Du1, Liming Li, Gary Whitlock, Derrick Bennett, Yu Guo, Zheng Bian, Junshi Chen, Paul Sherliker, Ying Huang, Ningmei Zhang, Xiangyang Zheng, Zhongxiao Li, Ruying Hu, Rory Collins, Richard Peto, Zhengming Chen, China Kadoorie Biobank Collaborative Group

Author Affiliations

1: Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK. huaidong.du@ctsu.ox.ac.uk.

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32

2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc (2011) 13.10

Correlates of adults' participation in physical activity: review and update. Med Sci Sports Exerc (2002) 10.85

Correlates of physical activity: why are some people physically active and others not? Lancet (2012) 8.19

What makes UK Biobank special? Lancet (2012) 3.72

Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol (2002) 3.38

Time use and physical activity: a shift away from movement across the globe. Obes Rev (2012) 2.83

China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol (2011) 2.82

Why have physical activity levels declined among Chinese adults? Findings from the 1991-2006 China Health and Nutrition Surveys. Soc Sci Med (2009) 2.70

The ABC of Physical Activity for Health: a consensus statement from the British Association of Sport and Exercise Sciences. J Sports Sci (2010) 2.70

Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol (2005) 2.70

Active commuting and cardiovascular disease risk: the CARDIA study. Arch Intern Med (2009) 2.24

Reproducibility and validity of the Shanghai Women's Health Study physical activity questionnaire. Am J Epidemiol (2003) 1.95

Physical inactivity, sedentary lifestyle and obesity in the European Union. Int J Obes Relat Metab Disord (1999) 1.88

Longitudinal relationships between occupational and domestic physical activity patterns and body weight in China. Eur J Clin Nutr (2007) 1.68

Physical activity by self-report: a brief history and future issues. J Phys Act Health (2012) 1.62

Disagreement in physical activity assessed by accelerometer and self-report in subgroups of age, gender, education and weight status. Int J Behav Nutr Phys Act (2009) 1.60

Enhancing the feasibility of large cohort studies. JAMA (2010) 1.56

Physical activity and sedentary leisure time and their associations with BMI, waist circumference, and percentage body fat in 0.5 million adults: the China Kadoorie Biobank study. Am J Clin Nutr (2013) 1.51

Associations between active travel to work and overweight, hypertension, and diabetes in India: a cross-sectional study. PLoS Med (2013) 1.44

Patterns and correlates of physical activity: a cross-sectional study in urban Chinese women. BMC Public Health (2007) 1.36

Work-related physical activity is not associated with body mass index and obesity. Obes Res (2002) 1.26

Physical activity patterns and their correlates among Chinese men in Shanghai. Med Sci Sports Exerc (2007) 1.25

Commuting, leisure-time physical activity, and cardiovascular risk factors in China. Med Sci Sports Exerc (2002) 1.25

Leisure-time physical activity alone may not be a sufficient public health approach to prevent obesity--a focus on China. Obes Rev (2008) 1.24

Cross-national comparisons of socioeconomic differences in the prevalence of leisure-time and occupational physical activity, and active commuting in six Asia-Pacific countries. J Epidemiol Community Health (2010) 1.18

Relationship of obesity to physical activity, domestic activities, and sedentary behaviours: cross-sectional findings from a national cohort of over 70,000 Thai adults. BMC Public Health (2011) 1.07

Relationships of occupational and non-occupational physical activity to abdominal obesity. Int J Obes (Lond) (2011) 1.07

Leisure time and occupational physical activity in relation to obesity and insulin resistance: a population-based study from the Skaraborg Project in Sweden. Metabolism (2011) 1.02

Patterns of physical activity in different domains and implications for intervention in a multi-ethnic Asian population: a cross-sectional study. BMC Public Health (2010) 0.99

Physical activity and clustered cardiovascular disease risk factors in young children: a cross-sectional study (the IDEFICS study). BMC Med (2013) 0.90

Physical activity and its association with cardiovascular risk factors in Vietnam. Asia Pac J Public Health (2010) 0.83

Associations of occupational, transportation, household and leisure-time physical activity patterns with metabolic risk factors among middle-aged adults in a middle-income country. Prev Med (2012) 0.83

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09

Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83

Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ (2004) 24.88

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet (2003) 17.34

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27

Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med (2013) 13.92

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet (2005) 12.92

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81

Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58

A nationally representative case-control study of smoking and death in India. N Engl J Med (2008) 10.21

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (2010) 10.21

Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med (2014) 9.25

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med (2009) 8.73

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Adult and child malaria mortality in India: a nationally representative mortality survey. Lancet (2010) 7.89

21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet (2012) 7.28

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet (2013) 7.25

Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet (2013) 7.04

Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet (2003) 6.58

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol (2009) 6.51

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet (2012) 6.49

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet (2002) 5.91

Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (2004) 5.19

Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med (2005) 5.05

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet (2010) 4.73

Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46

Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation (2008) 4.29

Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial. BMJ (2005) 4.27

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet (2010) 4.23

Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol (2005) 4.21

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet (2005) 4.20

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet (2007) 4.09

Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA (2007) 4.03

Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet (2009) 4.01

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology (2007) 3.87

New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85

Detection of large numbers of novel sequences in the metatranscriptomes of complex marine microbial communities. PLoS One (2008) 3.83

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79

Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet (2003) 3.71

UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68

Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med (2014) 3.64

Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol (2008) 3.56

Genome characteristics of facultatively symbiotic Frankia sp. strains reflect host range and host plant biogeography. Genome Res (2006) 3.53

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res (2005) 3.52

UK cancer survival statistics. BMJ (2010) 3.44

Analyses of cancer data from three ezetimibe trials. N Engl J Med (2008) 3.44

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA (2010) 3.34

Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med (2015) 3.29

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol (2013) 3.07

Stages of the cigarette epidemic on entering its second century. Tob Control (2012) 2.98

Population deworming every 6 months with albendazole in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial. Lancet (2013) 2.95

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation (2012) 2.90

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. J Infect Dis (2012) 2.89

China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol (2011) 2.82

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet (2004) 2.80